Histomorphometric effects of gemcitabine on Swiss albino mice spermatogenesis

Viveka, S; Udyavar, Ajay; Kuriakose, Santhosh; Sudha, MJ

Histomorphometric effects of gemcitabine on Swiss albino mice spermatogenesis

Authors

¹ Department of Anatomy, Azeezia Institute of Medical Sciences, Meeyannoor, Kollam, Kerala, India

² Department of Anatomy, A.J. Institute of Medical Sciences, Mangalore, Karnataka, India

³ Department of Anatomy, Amala Institute of Medical Sciences, Thrissur, Kerala, India

⁴ Department of Pharmacology, Azeezia Institute of Medical Sciences, Meeyannoor, Kollam, Kerala, India

Abstract

Background: Spermatogenesis is a highly conserved and regulated process and it is sensitive to fluctuations in the physical and chemical environment. Gemcitabine is a novel antimetabolic anticancer drug used frequently in the treatment of many cancers. This study aimed to investigate the histomorphometric effects of gemcitabine on spermatogenesis in Swiss albino mice.
Materials and Methods: Gemcitabine in high and low doses (80 and 40 mg/kg) injected intraperitoneally to inbred Swiss albino mice. Gross testicular features and seminiferous tubular histomorphometry was studies at the end of 7 ^th , 14 ^th day and at 2 months sperm shape abnormalities were studied.
Results: Seminiferous tubular morphology was altered significantly, showing a reduction in height, perimeter and area in a dose dependent manner. Sertoli cell number decreased. Basement membrane thickness was reduced and it appeared to be permanent, with statistically insignificant changes even after 2 months. There was a reduction of intertubular spaces. Sperms have shown banana heading, decapitation and loss of normal hook of head. The effects were partially reversible at the end of 2 months.
Conclusion: It was concluded that gemcitabine affects the process of spermatogenesis adversely in a dose and time dependent manner and the effects are partially reversible.

Keywords

References

1.	Song GS. Could sperm quality be affected by a building environment? A literature review. Build Environ 2010;45:936-43.
2.	Pizzorno G, Handschumacher RE, Cheng YC. Pyrimidine and purine antimetabolites. In: Bast RC Jr, Kufe DW, Pollock RE, Editors. Holland-Frei Cancer Medicine. 6 ^th ed. Hamilton, ON: BC Decker; 2003.
3.	Konishi H, Nagai K. Expression of nucleoside transporters in the mouse testis and ovary. Am J Biochem Biotechnol 2013;6:448-52.
4.	Sigman M, Mehta A. Chemotherapy effects on spermatogenesis. In: Mulhall JP, Applegarth LD, Oates RD, Schlegel PN, editors. Impact of Cancers and Treatment on Male Fertility. London: Cambridge University: Health and Fitness; 2013. p. 114-5.
5.	Takimoto CH, Calvo E. Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer Management: A Multidisciplinary Approach. 11 ^th ed. CMP Medica 2008.
6.	Abu-Baker SO. Gemcitabine impacts histological structure of mice testis and embryonic organs. Pak J Biol Sci 2009;12:607-15.
7.	Gemcitabine, USP DI. Vol 1, Drug information for health care professional [Update monographs], Englewood, Colorador, Micromedex, Inc, 1999.
8.	Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr 2005; 34:6-8.
9.	Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 1982;42:122-31.
10.	Russell LD, Russell JA. Short-term morphological response of the rat testis to administration of five chemotherapeutic agents. Am J Anat 1991;192:142-68.
11.	Avadhani R, Kumar A. Sperm shape abnormalities in mice treated with vincristine sulphate. J Int Med Sci Acad 1994;7:9-13.
12.	Adler ID. Synopsis of the in vivo results obtained with the 10 known or suspected aneugens tested in the CEC collaborative study. Mutat Res 1993;287:131-7.
13.	Prasad AM, Ramnarayan K, Bairy KL. Effect of imatinib on histological parameters in male Swiss albino mice. Int J Pharm Sci Rev Res 2010;4:116-22.
14.	Hacker-Klom UB, Meistrich ML, Göhde W. Effect of doxorubicin and 4'-epi-doxorubicin on mouse spermatogenesis. Mutat Res 1986;160:39-46.
15.	Ficsor G, Ginsberg LC. The effect of hydroxyurea and mitomycin C on sperm motility in mice. Mutat Res 1980;70:383-7.
16.	Nakagawa S, Nakamura N, Fujioka M, Mori C. Spermatogenic cell apoptosis induced by mitomycin C in the mouse testis. Toxicol Appl Pharmacol 1997;147:204-13.
17.	Mishra RK, Singh SK. Effect of aqueous leaf extract of Azadirachta indica on the reproductive organs in male mice. Indian J Exp Biol 2005;43:1093-103.
18.	Singh A, Singh SK. Evaluation of antifertility potential of Brahmi in male mouse. Contraception 2009;79:71-9.
19.	Singh SK, Chakravarty S. Antispermatogenic and antifertility effects of 20,25-diazacholesterol dihydrochloride in mice. Reprod Toxicol 2003;17:37-44.
20.	Meistrich ML. Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy. Br J Cancer Suppl 1986;7:89-101.
21.	Jagetia GC, Krishnamurthy H, Jyothi P. Evaluation of cytotoxic effects of different doses of vinblastine on mouse spermatogenesis by flow cytometry. Toxicology 1996;112:227-36.
22.	Styrna J, Kilarski W, Krzanowska H. Influence of the CBA genetic background on sperm morphology and fertilization efficiency in mice with a partial Y chromosome deletion. Reproduction 2003;126:579-88.
23.	Company, Elli Lilly. Material Safety Data Sheet. Section 11 Toxicological Information, 2005. Available from: http://www.web.ncifcrf.gov/rtp/LASP/intra/forms/msds/msds_Gemcitabine.pdf. [Last cited on 2009 Sep 02].
24.	Viville S, Mollard R, Bach ML, Falquet C, Gerlinger P, Warter S. Do morphological anomalies reflect chromosomal aneuploidies? Case report. Hum Reprod 2000;15: 2563-6.
25.	Hermo L, Pelletier RM, Cyr DG, Smith CE. Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: Background to spermatogenesis, spermatogonia, and spermatocytes. Microsc Res Tech 2010;73:241-78.

Advanced Biomedical Research